Clinical Research Directory
Browse clinical research sites, groups, and studies.
Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)
Sponsor: Montefiore Medical Center
Summary
This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.
Official title: Outcomes of Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma; Middle Meningeal Artery Embolization for Chronic Subdural Hematoma (MESH)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2023-12-05
Completion Date
2026-08
Last Updated
2026-01-07
Healthy Volunteers
No
Conditions
Locations (19)
Baptist Health South Florida, Inc.
Coral Gables, Florida, United States
Mayo Clinic Florida
Jacksonville, Florida, United States
Orlando Regional Medical Center
Orlando, Florida, United States
University of Illinois Chicago
Chicago, Illinois, United States
University of Chicago Medicine
Chicago, Illinois, United States
The University of Iowa
Iowa City, Iowa, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School
Boston, Massachusetts, United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
Montefiore Medical Center
The Bronx, New York, United States
Geisinger Health
Danville, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
UTHealth Houston
Houston, Texas, United States
HCA Houston Healthcare Kingwood
Kingwood, Texas, United States
Austin Health
Heidelberg, Victoria, Australia
Unity Health Toronto
Toronto, Ontario, Canada
University of Toronto
Toronto, Ontario, Canada
Toronto Western Hospital
Toronto, Ontario, Canada